Publicaciones en colaboración con investigadores/as de Hospital Miguel Servet (6)

2024

  1. Author Correction: Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma (Scientific Reports, (2024), 14, 1, (4561), 10.1038/s41598-024-55287-z)

    Scientific Reports

  2. Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma

    Scientific Reports, Vol. 14, Núm. 1

  3. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

  4. XEN® 45 en el manejo quirúrgico del glaucoma en fases tempranas: estudio nacional de consenso según metodología Delphi

    Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 3, pp. 98-108

2022

  1. Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

    Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324

2017

  1. Diagnostic ability of Humphrey perimetry, Octopus perimetry, and optical coherence tomography for glaucomatous optic neuropathy

    Eye (Basingstoke), Vol. 31, Núm. 3, pp. 443-451